According to a new report by Polaris Market Research, the global Oral Solid Dosage Contract Manufacturing market was valued at USD 10.99 billion in 2026 and is projected to reach USD 22.62 billion by 2034, expanding at a CAGR of 9.4% over the forecast period. Growth is underpinned by rising pharmaceutical outsourcing, expanding generic drug manufacturing demand, and accelerating adoption...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek